Latest Press Releases
More Press Releases
NAMSA and Lexitas Announce Strategic Partnership to Deliver End-to-End Ophthalmic Medical Device Development
TOLEDO, Ohio and DURHAM, N.C., April 30, 2026
Xtract One Selected to Support School Safety Across Granville County Public Schools
Gateway’s AI-Powered Weapons Detection Systems Help Ensure Efficient Screening of Students and Staff
CCC Intelligent Solutions Announces Chief Financial Officer Transition
Rodney Christo Named Interim CFO and Chief Accounting Officer
Medicenna and Fondazione Melanoma Onlus Announce Presentation on NEOCYT Trial at ASCO 2026
NEO-CYT is a randomized, multi-centre trial of neoadjuvant MDNA11 (before curative intent surgery) sponsored by the
Palvella Therapeutics to Host First Quarter 2026 Financial Results and Corporate Update Conference Call on May 7, 2026
WAYNE, Pa., April 30, 2026 (GLOBE NEWSWIRE) — Palvella Therapeutics, Inc. (Palvella or “the Company”) (Nasdaq: PVLA),
Notice of Knight Therapeutics’ First Quarter 2026 Results Conference Call
MONTREAL, April 30, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a pan-American (ex-USA)
Hubbell Reports First Quarter 2026 Results
Shelton, CT, April 30, 2026 (GLOBE NEWSWIRE) — HUBBELL REPORTS FIRST QUARTER 2026 RESULTS Q1 diluted EPS of $3.41;
Barinthus Bio Reports First Quarter 2026 Financial Results and Updates on Corporate Developments
Proposed combination with Clywedog Therapeutics Inc. (“Clywedog”) progressing towards closing which will result in a
Dragonfly Energy to Report First Quarter 2026 Financial and Operational Results on May 14, 2026
RENO, Nev., April 30, 2026 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (Nasdaq: DFLI) (“Dragonfly Energy” or
Ealixir Launches Beta of RepuTrust, an AI-Powered Digital Identity Platform, Granting Early Access to Our Select Users
Introducing a New Way to Measure and Understand Online Reputation, Powered by ReputScore — Ealixir's Proprietary